ZA200507100B - Process for preparing a polymorph of rosigitazone maleate - Google Patents
Process for preparing a polymorph of rosigitazone maleate Download PDFInfo
- Publication number
- ZA200507100B ZA200507100B ZA200507100A ZA200507100A ZA200507100B ZA 200507100 B ZA200507100 B ZA 200507100B ZA 200507100 A ZA200507100 A ZA 200507100A ZA 200507100 A ZA200507100 A ZA 200507100A ZA 200507100 B ZA200507100 B ZA 200507100B
- Authority
- ZA
- South Africa
- Prior art keywords
- compound
- solvent
- rosiglitazone maleate
- mixture
- rosiglitazone
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0307259.2A GB0307259D0 (en) | 2003-03-28 | 2003-03-28 | Process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200507100B true ZA200507100B (en) | 2006-07-26 |
Family
ID=9955778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200507100A ZA200507100B (en) | 2003-03-28 | 2005-09-05 | Process for preparing a polymorph of rosigitazone maleate |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US20070167494A1 (https=) |
| EP (1) | EP1615918A1 (https=) |
| JP (1) | JP2006521340A (https=) |
| KR (1) | KR20050120670A (https=) |
| CN (1) | CN1768057A (https=) |
| AU (2) | AU2004224068A1 (https=) |
| BR (1) | BRPI0408752A (https=) |
| CA (1) | CA2520249A1 (https=) |
| EA (1) | EA009331B1 (https=) |
| EC (1) | ECSP056038A (https=) |
| GB (1) | GB0307259D0 (https=) |
| IS (1) | IS8087A (https=) |
| MA (1) | MA27727A1 (https=) |
| MX (1) | MXPA05010413A (https=) |
| NO (1) | NO20054911L (https=) |
| OA (1) | OA13042A (https=) |
| WO (1) | WO2004085435A1 (https=) |
| ZA (1) | ZA200507100B (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20020137940A1 (en) | 1997-12-16 | 2002-09-26 | Smithkline Beecham P.L.C. | 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| US20040248945A1 (en) | 1999-04-23 | 2004-12-09 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| GB2405403A (en) * | 2003-08-29 | 2005-03-02 | Cipla Ltd | Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base |
| ITMI20041537A1 (it) * | 2004-07-28 | 2004-10-28 | Chemi Spa | Nuova forma polimorfa del rosiglitazone maleato |
| CZ298424B6 (cs) * | 2005-05-24 | 2007-09-26 | Zentiva, A. S. | Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel |
| WO2018140092A1 (en) | 2017-01-27 | 2018-08-02 | Obrien Christopher F | Methods for the administration of certain vmat2 inhibitors |
| ES3024958T3 (en) | 2017-09-21 | 2025-06-05 | Neurocrine Biosciences Inc | High dosage valbenazine formulation and compositions, methods, and kits related thereto |
| JP2021502959A (ja) | 2017-10-10 | 2021-02-04 | ニューロクライン バイオサイエンシーズ，インコーポレイテッド | 特定のｖｍａｔ２インヒビターを投与するための方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9218830D0 (en) * | 1992-09-05 | 1992-10-21 | Smithkline Beecham Plc | Novel compounds |
| GB9723295D0 (en) * | 1997-11-04 | 1998-01-07 | Smithkline Beecham Plc | Novel process |
| UA67844C2 (uk) * | 1999-04-23 | 2004-07-15 | Смітклайн Бічам Плс | Поліморф 5-[4-[2-(n-метил-n-(2-піридил)аміно)етокси]бензил]тіазолідин-2,4-діону солі малеїнової кислоти |
| PL351685A1 (en) * | 1999-04-23 | 2003-06-02 | Smithkline Beecham Plc | Novel pharmaceutical |
| DE60004658T2 (de) * | 1999-04-23 | 2004-06-24 | Smithkline Beecham Plc, Brentford | Thiazolidindionderivat und seine verwendung als antidiabetikum |
| CZ2003864A3 (cs) * | 2000-09-26 | 2004-01-14 | Dr. Reddy´S Research Foundation | Nové polymorfní formy 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl]thiazolidin-2,4-dion-maleátu a způsob jejich přípravy |
-
2003
- 2003-03-28 GB GBGB0307259.2A patent/GB0307259D0/en not_active Ceased
-
2004
- 2004-03-25 KR KR1020057018143A patent/KR20050120670A/ko not_active Withdrawn
- 2004-03-25 BR BRPI0408752-6A patent/BRPI0408752A/pt not_active IP Right Cessation
- 2004-03-25 OA OA1200500267A patent/OA13042A/en unknown
- 2004-03-25 WO PCT/GB2004/001306 patent/WO2004085435A1/en not_active Ceased
- 2004-03-25 CA CA002520249A patent/CA2520249A1/en not_active Abandoned
- 2004-03-25 US US10/551,021 patent/US20070167494A1/en not_active Abandoned
- 2004-03-25 EP EP04723254A patent/EP1615918A1/en not_active Withdrawn
- 2004-03-25 CN CNA2004800083916A patent/CN1768057A/zh active Pending
- 2004-03-25 AU AU2004224068A patent/AU2004224068A1/en not_active Abandoned
- 2004-03-25 EA EA200501527A patent/EA009331B1/ru unknown
- 2004-03-25 MX MXPA05010413A patent/MXPA05010413A/es unknown
- 2004-03-25 JP JP2006506028A patent/JP2006521340A/ja not_active Withdrawn
-
2005
- 2005-09-05 ZA ZA200507100A patent/ZA200507100B/en unknown
- 2005-09-26 EC EC2005006038A patent/ECSP056038A/es unknown
- 2005-10-11 MA MA28549A patent/MA27727A1/fr unknown
- 2005-10-24 NO NO20054911A patent/NO20054911L/no not_active Application Discontinuation
- 2005-10-24 IS IS8087A patent/IS8087A/is unknown
-
2008
- 2008-10-30 AU AU2008237610A patent/AU2008237610A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| OA13042A (en) | 2006-11-10 |
| IS8087A (is) | 2005-10-24 |
| EA200501527A1 (ru) | 2006-02-24 |
| EA009331B1 (ru) | 2007-12-28 |
| CN1768057A (zh) | 2006-05-03 |
| MXPA05010413A (es) | 2005-11-04 |
| BRPI0408752A (pt) | 2006-03-28 |
| NO20054911L (no) | 2005-10-24 |
| KR20050120670A (ko) | 2005-12-22 |
| AU2008237610A1 (en) | 2008-11-27 |
| US20070167494A1 (en) | 2007-07-19 |
| JP2006521340A (ja) | 2006-09-21 |
| AU2004224068A1 (en) | 2004-10-07 |
| WO2004085435A1 (en) | 2004-10-07 |
| EP1615918A1 (en) | 2006-01-18 |
| CA2520249A1 (en) | 2004-10-07 |
| MA27727A1 (fr) | 2006-01-02 |
| ECSP056038A (es) | 2006-01-27 |
| GB0307259D0 (en) | 2003-05-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2008237610A1 (en) | Process for preparing a polymorph of rosiglitazone maleate | |
| US7235691B2 (en) | Crystalline forms of modafinil | |
| US8722722B2 (en) | Raltegravir salts and crystalline forms thereof | |
| WO2007109799A2 (en) | Polymorphs of eszopiclone malate | |
| JP2000511875A (ja) | 抗糖尿病活性を増強されたトログリタゾンの新規な多形型及びそれらの製造方法 | |
| US8063214B2 (en) | Polymorphic forms of tadalafil | |
| EP1789412B1 (en) | Crystalline alfuzosin base | |
| US20090012296A1 (en) | Processes for the preparation of crystalline form beta of imatinib mesylate | |
| CA2464961A1 (en) | Polymorphous forms of rosiglitazone maleate | |
| CN110092786A (zh) | 吴茱萸碱的制造方法 | |
| JP2020083892A (ja) | ベラプロスト−３１４ｄ・一水和物結晶及びその製造方法 | |
| JP4411269B2 (ja) | （ｒ）−３−［［（４−フルオロフェニル）スルホニル］アミノ］−１，２，３，４−テトラヒドロ−９ｈ−カルバゾール−９−プロパン酸（ラマトロバン）の熱力学的に安定な形態の結晶の製造方法 | |
| US7173153B2 (en) | Sertraline hydrochloride form II and methods for the preparation thereof | |
| EA008055B1 (ru) | Кристаллические формы оланзапина и способы их получения | |
| US20090227645A1 (en) | Pharmaceutical compositions of valdecoxib | |
| US12522576B2 (en) | Polymorphs of D9-THC naphthoylester | |
| EP1730153B1 (en) | Isopropanol water solvate of olanzapine | |
| AU700976B2 (en) | Novel polymorphic forms of troglitazone having enhanced anti-diabetic activity and a process for their preparation | |
| WO2006010653A1 (en) | New polymorphous form of rosiglitazone maleate | |
| WO2007017890A2 (en) | Process for preparation of pantoprazole sodium sesquihydrate and product prepared therby | |
| JP3780436B2 (ja) | α−テトラ置換フタロシアニンの製造法 | |
| WO2021250624A1 (en) | Novel crystalline compound of vadadustat | |
| MXPA03001827A (es) | Proceso para la preparacion de hidratos de olanzapina y su conversion a formas cristalinas de olanzapina. | |
| ZA200404332B (en) | A novel polymorph of sertraline hydrochloride and composition containing thereof, novel methods for preparation of sertraline hydrochloride polymorphs and amorphous form. | |
| EP2109613A2 (en) | Polymorphs of eszopiclone malate |